Jean W. Marstiller
Bedrijfssecretaris bij CUMBERLAND PHARMACEUTICALS INC.
Profiel
Jean W.
Marstiller is currently working as the Secretary & Senior VP-Administrative Services and Secretary & Senior Vice President at Cumberland Pharmaceuticals, Inc. since 2012.
Previously, Jean worked as the Director-Administrative Operations at Therapeutic Antibodies, Inc. from 1989 to 1998 and as a Principal at Brown-Forman Corp.
from 1982 to 1987.
Jean completed their undergraduate degree at Vanderbilt University.
Actieve functies van Jean W. Marstiller
| Bedrijven | Functie | Begin |
|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC. | Bedrijfssecretaris | 06-01-1999 |
Eerdere bekende functies van Jean W. Marstiller
| Bedrijven | Functie | Einde |
|---|---|---|
Therapeutic Antibodies, Inc.
 Therapeutic Antibodies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., Therapeutic Antibodies, Inc. is a biopharmaceutical company that specializes in research and development to produce polyclonal antibodies. The company is based in Nashville, TN. Therapeutic Antibodies was acquired by Protherics Plc on September 15, 1999 for $38.46 million. | Hoofd Administratief Officier | 01-01-1998 |
| BROWN-FORMAN CORPORATION | Corporate Officer/Principal | 01-01-1987 |
Opleiding van Jean W. Marstiller
| Vanderbilt University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BROWN-FORMAN CORPORATION | Consumer Non-Durables |
| CUMBERLAND PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Therapeutic Antibodies, Inc.
Therapeutic Antibodies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., Therapeutic Antibodies, Inc. is a biopharmaceutical company that specializes in research and development to produce polyclonal antibodies. The company is based in Nashville, TN. Therapeutic Antibodies was acquired by Protherics Plc on September 15, 1999 for $38.46 million. | Commercial Services |
